Orange County NC Website
Browse       Search
Black Non-Hispanic <br />Native Hawaiian or Other Pacific Islander Non-Hispanic <br />White Non-Hispanic <br />Hispanic <br />Some Other Race or Multiple Races <br />Unknown <br />Sum total of unique participants served (Autocalculated) <br />Does sum total (C35) match the reported # of unique participants <br />(C25)? (Autocalculated)Yes <br />Description Count Quality Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure <br /># of unique participants, who use opioids and/or have OUD, served, <br />who report they are satisfied with services <br /># of unique participants, who use opioids and/or have OUD, served <br /># of referrals to addiction treatment, recovery supports, harm <br />reduction services, primary healthcare, and other services that result <br />in linkage to supports/services <br /># of referrals to addiction treatment, recovery supports, harm <br />reduction services, primary healthcare, and other services <br /># of staff with lived experience with OUD <br /># of staff <br /># of unique participants, who use opioids and/or have OUD, served <br />who received naloxone kit <br /># of unique participants, who use opioids and/or have OUD, served <br />Description Count Outcome Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure <br /># of unique participants with OUD served who were connected to <br />treatment and adhered to treatment <br />STRATEGY-SPECIFIC QUALITY MEASURES <br />Quality measures answer the question, “How well did you do it?”. Please quantify the quality measures relevant to your implementation of this strategy. Quality measures should reflect numbers during the time period January 1, 2024 through <br />December 31, 2024. <br />% of participants, who use opioids <br />and/or have OUD, who are satisfied <br />w/ services <br />Incomplete <br />A unique participant may participate in multiple treatment programs so <br />there may be some duplication of unique participants when numbers <br />across programs, project, sites, etc., are aggregated for the strategy- <br />specific impact report. A participant may receive services across local <br />government boundaries (e.g., a person with OUD may reside in one county <br />and receive services in another county). <br />% of referrals that results in linkage <br />(e.g., first appointment)Incomplete <br />% of staff with lived experience with <br />OUD Incomplete <br />% of participants who received <br />naloxone kit Incomplete <br />A naloxone kit contains two doses. <br />A unique participant may participate in multiple treatment programs so <br />there may be some duplication of unique participants when numbers <br />across programs, project, sites, etc., are aggregated for the strategy- <br />specific impact report. A participant may receive services across local <br />government boundaries (e.g., a person with OUD may reside in one county <br />and receive services in another county). <br />STRATEGY-SPECIFIC OUTCOME MEASURES (PROGRAM-LEVEL) <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Outcome measures answer the question, “Is anyone better off?”. Outcome measures can be at the program- or population-level. Please quantify the outcome measures relevant to your implementation of this strategy. Outcome measures should reflect <br />numbers during the time period January 1, 2024 through December 31, 2024. <br />% of patients with OUD who adhere <br />to treatment months after first <br /> <br />Incomplete <br />Recommended measure at six months. If measure for adherence is taken <br />at another increment, please describe this in the "Notes" column. <br />A unique participant may participate in multiple treatment programs so <br />there may be some duplication of unique participants when numbers <br /> <br /> <br /> <br /> <br />DocuSign Envelope ID: 3ACB2BD5-B5DB-4475-96AC-9D0A6C22362D